or Try an Advanced Search...

    Non Small Cell Lung Cancer Stocks List

    Symbol Grade Name % Change
    EVAX D Evaxion Biotech A/S 3.84
    GMAB F Genmab A/S 0.72
    GNLX F Genelux Corporation -5.21
    HCM B Hutchison China MediTech Limited -2.09
    LCTX C Lineage Cell Therapeutics, Inc. -0.39
    LYEL C Lyell Immunopharma, Inc. -0.79
    NVCR D NovoCure Limited 0.32
    NXTC D NextCure, Inc. -2.42
    OPK C OPKO Health Inc. -0.38
    PBYI D Puma Biotechnology Inc 3.14
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Small Cell Lung Cancer Immunotherapy Immunotherapies Ovarian Cancer Pancreatic Cancer Solid Tumors Advanced Cancer Biology Biopharmaceutical Clinical Trial Life Sciences Stem Cell Treatment Of Ovarian Cancer Tumor Virotherapy Active Pharmaceutical Ingredients

    Related ETFs - A few ETFs which own one or more of the above listed Non Small Cell Lung Cancer stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 4.77
    FBT D First Trust Amex Biotech Index Fund 3.28
    GERM C ETFMG Treatments Testing and Advancements ETF 2.38
    IBB D iShares Nasdaq Biotechnology Index Fund 1.83
    HTEC D Robo Global Healthcare Technology and Innovation ETF 1.38
    View all Non Small Cell Lung Cancer ETFs...
    Compare ETFs
    Compare FBT to GERM Compare FBT to IBB Compare GERM to IBB

        Non Small Cell Lung Cancer Stocks Recent News

        Date Stock Title
        May 7 EVAX Sidoti Events, LLC's Virtual May Micro-Cap Conference
        May 7 LYEL Lyell Immunopharma First Quarter 2024 Earnings: US$0.24 loss per share (vs US$0.27 loss in 1Q 2023)
        May 6 OPK OPKO Health Q1 Earnings Preview
        May 6 LYEL Lyell Immunopharma reports Q1 results
        May 6 LYEL Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
        May 6 LCTX OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
        May 5 PBYI Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results
        May 5 GNLX Genelux Corporation's (NASDAQ:GNLX) market cap rose US$11m last week; individual investors who hold 54% profited and so did insiders
        May 5 PBYI Puma Biotechnology: A Story In Flux Heading Into Mid-2024
        May 4 PBYI Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        May 3 NVCR NovoCure Limited Q1 Earnings: Core Business Accelerating
        May 3 PBYI Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
        May 3 GMAB Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
        May 3 NVCR NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript
        May 3 PBYI Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat
        May 3 OPK OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024
        May 3 PBYI Puma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...
        May 3 NVCR NovoCure (NVCR) Q1 2024 Earnings Call Transcript
        May 3 PBYI Puma Biotechnology, Inc. (PBYI) Q1 2024 Earnings Call Transcript
        May 2 PBYI Puma Biotechnology, Inc. 2024 Q1 - Results - Earnings Call Presentation
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Small Cell Lung Cancer Immunotherapy Immunotherapies Ovarian Cancer Pancreatic Cancer Solid Tumors Advanced Cancer Biology Biopharmaceutical Clinical Trial Life Sciences Stem Cell Treatment Of Ovarian Cancer Tumor Virotherapy Active Pharmaceutical Ingredients
        Non Small Cell Lung Cancer

        Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all cases. It is a type of cancer that begins in the cells that line the airways of the lungs. NSCLC is divided into three main subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Symptoms of NSCLC include a persistent cough, chest pain, shortness of breath, and coughing up blood. Treatment options for NSCLC include surgery, chemotherapy, radiation therapy, and targeted therapy.

        Browse All Tags